Neural tissues from specific pathogen-free ponies that had been experimentally infected with equine herpesvirus 1 (EHV-1) were analysed by in situ hybridization. Digoxigenin-labelled EHV-1 BamHI fragments spanning almost the entire EHV-1 genome were hybridized to RNA in tissue sections from latently infected trigeminal ganglia. The BamHI E fragment detected EHV-1 RNA antisense to gene 63 (HSV-1 homologue ICP0) in a small number of neurons. Sixteen other BamHI fragments gave negative results in 20 sections tested with each fragment. Latency associated transcripts (LATs) were localized to the neuronal nuclei. EHV-1 nucleotide sequence data in the region reveals the presence of a putative EHV-1 LAT promoter that shares similar motifs with the HSV-1 LAT promoter, including the LAT promoter-binding factor, and may have a role in EHV-1 LAT expression.
Equine herpesvirus 1 (EHV-1) is a member of the Alphaherpesvirinae (Roizman, 1990; Telford et al., 1992) . Members of this family, such as herpes simplex virus type 1 (HSV-1), varicella-zoster virus (VZV), bovine herpesvirus 1 (BHV-1), pseudorabies virus (PRV) and feline herpesvirus 1 (FHV-1), establish life-long latency. The site of latency is primarily (but not exclusively) nervous tissue, particularly sensory ganglia (Roizman, 1990) .
Like other alphaherpesviruses, EHV-1 establishes latent infections from which reactivation occurs following appropriate stimuli (Edington et al., 1985; Gibson et al., 1992) . Generally, EHV-1 was regarded as nonneurotropic (Allen & Bryans, 1986) , although recent studies have shown the presence of viral EHV-1 DNA by PCR in neuronal tissues (Welch et al., 1992; Slater et al., 1994; Edington et al., 1994) as well as in a variety of lymphoid tissues. Furthermore, explants from trigeminal ganglia of specific pathogen-free (SPF) ponies which were experimentally infected with EHV-1 were viruspositive on co-cultivation (Slater et al., 1994) .
Based on murine HSV infection models of latency, it appears that most of the virus genome is transcriptionally inactive during latency. However, limited transcription occurs from one region of the genome in latently infected neurons. Three collinear transcripts of 2.0, 1.5 and 1.45 kb have been detected by Northern blot analysis of latently infected ganglia (Fraser et al., 1992) . These * Author for correspondence. Fax +44 1223 332998. e-mail hjfl0@cam.ac.uk latency associated transcripts (LATs) overlap the 3' end of gene 1CP0, are transcribed from the complementary DNA strand and are observed in the nuclei of ganglionic neurons by in situ hybridization (Dobson et al., 1989; Fraser et al., 1992) . Studies on BHV-1, PRV-1 and FHV-1 have also shown that a limited region of viral genome is transcribed in the ganglionic neurons during latency (Rock et al., 1987; Cheung, 1989; Ohmura et al., 1993) .
Although latent EHV-1 has been reactivated from both neural and lymphoid tissues, the key questions concerning the cellular location and transcriptional activity during latency are unresolved. In this study we describe the analysis of neural tissues obtained from ponies infected experimentally with EHV-1. We report the detection of latent EHV-1 in neurons of the trigeminal ganglion and present the first evidence that at least some of the cells which contain EHV-1 are transcriptionally active during latency.
EHV-1 strain Ab4p (Telford et al., 1992; Gibson et al., 1992) was grown and titrated according to published methods (Gibson et al., 1992; Slater et al., 1994) . SPF ponies were infected according to the experimental protocol of Slater et al. (1994) . Fourteen weeks postinfection, trigeminal ganglia were obtained from four ponies at post mortem. One ganglion from each was tested for infectious virus by co-cultivation (Slater et al., 1994) . The other ganglion was snap-frozen in liquid nitrogen and stored at -70 °C. One portion of tissue was used for RNA isolation and PCR and another was fixed in periodate-lysine-paraformaldehyde for 2 h, trans-0001-3475 © 1995 SGM ferred to 50 % ethanol and then paraffin-embedded for in situ hybridization studies. DNA probes from BamHI restriction fragments A-Q, derived from EHV-1 strain HVS25A genomic DNA and cloned into the vector pBR322 (Whalley et al., 1981) were used, together with a PstI restriction fragment of the BamHI E fragment, subcloned into the pUC 18 vector (Fig. 1) . The p B R 3 2 2 / B a m H I and pUC18/PstI clones were digested with BamHI and PstI, respectively. The insert DNA was gel-purified and randomly labelled with digoxigenin according to the manufacturer's instructions (Boehringer Mannheim). The efficiency of labelling of each restriction fragment was assessed by dot blot assay. RNA probes were prepared from a NarI restriction fragment ( Fig. 1 ) that was derived from the BamHI E fragment and cloned in both orientations into the vector pBS + (Stratagene). In vitro 'run-off' transcriptions of the linearized NarI subclones, using the pBS + T7 RNA polymerase promoter, gave rise to riboprobes which encode sequences complementary (Ri) and sense (Rii) to ORF63 mRNA. In vitro transcription was performed according to the manufacturer's recommendations (Boehringer Mannheim). From each transcription reaction approximately 0.5 to 2.0gg of RNA was recovered, as determined by incorporation of the radioactive tracer [32p]UTP.
In situ hybridization was performed according to Hukkanen et al. (1990) with slight modifications. Tissue sections were hybridized overnight at 42 °C for DNA and 70 °C for RNA probes; unbound probe was removed by washing sequentially in 2 x SSC five times for 10 min followed by a wash at 55 °C for 30 min for DNA probes and 75 °C for RNA probes, and a final 30 min wash in 0"1 x SSC at 42°C. Antibody detection and colour development were carried out according to manufacturer's instructions (Boehringer Mannheim).
Ponies were monitored for EHV-1 shedding by cocultivation and PCR for 6 weeks prior to sacrifice; no virus was detected during this period. Following post mortem, virus was reactivated from the trigeminal ganglia of two ponies by co-cultivation, while ganglia from two were negative for reactivation. However, the contralateral trigeminal ganglia from all four ponies were found to be positive for EHV-1 DNA by nested PCR, as reported by Slater et al. (1994) . The same four trigeminal ganglia were used to prepare the tissue sections. No obvious histological abnormalities were observed. Digoxigenin-labelled cloned fragments of the EHV-1 genome were used individually to detect EHV-1 RNA by in situ hybridization. All the sections probed for RNA were treated with DNase to digest viral DNA. Examples from positive and negative sections are shown (Fig. 2) . One fragment only, the BamHI E fragment, yielded positive results in sections obtained from 2 out of 4 ponies (Fig. 2b) . The digoxigenin staining was restricted to cells that were identified morphologically as neurons and was localized to their nuclei. Six positive neurons were observed among approximately 30000 neurons examined (0.02%). None of the remaining probes produced a positive signal in approximately 3000 neurons examined in 20 sections for each probe (Fig. 2a) . All the probes, including BamHI E, were negative in control sections of uninfected murine trigeminal ganglia. All probes hybridized to infected RK-13 cell cultures and to sections of lung from EHV-l-infected mice (data not shown). In order to map further the region of the EHV-1 genome being transcribed, hybridization studies were performed using a digoxigenin-labelled Pst! subfragment of the BamHI E fragment and the single-stranded RNA probes Ri and Rii transcribed from the NarI subfragment of BamHl E (Fig. 1) . The PstI fragment (which spanned the 3' end of gene 64 and the 5' end of gene 63), produced no signal in 40 sections examined (approximately 6000 neurons). In addition, no signal was detected in 40 more sections, when the labelled single-stranded RNA probe Ri, (encoding sequences complementary to the Y end of gene 63 mRNA), was used in in situ hybridization studies of latently infected ganglia (Fig. 2c) . In contrast, the riboprobe Rii, which encoded sequences of the same sense as the gene 63 mRNA (Fig. 1) hybridized to one neuron in 40 sections (approximately 6000 neurons) of trigeminal ganglia (Fig. 2d) .
The answers to several key questions concerning EHV-1 emerged from this study: (i) equine neurons were defined as a cellular site of EHV-1 latency; (ii) a very small proportion of neurons were transcriptionally active during latency; and (iii) at least one region of the EHV-1 genome is transcriptionally active. The transcripts concerned were detected by the BamHI E fragment which encodes genes 64 (HSV homologue ICP4), 63 (HSV homologue ICP0) and the 5' end of gene 62. However the use of subclones suggested that the region around the 3' end of gene 63 is active during latency• The riboprobes revealed that LATs are transcribed from the strand opposite to ORF63. Finally, the LATs were localized to the neuronal nuclei-: These findings are consistent with those obtained for HSV-1, BHV-1, PRV-1 and FHV-1, where latency transcripts mapping antisense to immediate early genes have been demonstrated in sensory ganglia.
The BamHI E fragment hybridized to a total of six neurons among approximately 30 000 examined (0.02 %). Although a large number of neurons were examined, no positive signal was detected with any other fragment. However, because the incidence of positive neurons is so low, the possibility of other regions of the EHV-1 genome being transcribed cannot be excluded. For HSV-1, using in situ PCR to detect DNA, the number of neurons which contain HSV-1 DNA was reported as 10 % (Mehta et at., 1995) ; this is higher than the number of neurons positive for LATs by in situ hybridization (approximately 1%), suggesting that a proportion of DNA-positive cells may be LAT-negative. The number of ganglionic cells harbouring EHV-1 DNA is unknown, but it remains a possibility that additional cells may be present which contain EHV-1 DNA but do not express LATs. To date, we have been unable to detect mRNA by Northern blot analysis. This further substantiates the possibility that the number of positive neurons in latently infected ganglia is extremely low and this may explain why ganglia from naturally infected horses are often negative by PCR (K. Borchers, personal communication).
For HSV-1, the synthesis of LATs during latency is regulated by a promoter located approximately 700 nucleotides upstream of the 2-0 kb LAT ( Fig. 3b ; Dobson et al., 1989; Batchelor & O'Hare, 1990; Zwaagstra et al., 1991) . This region contains consensus sequences for a common RNA polymerase II promoter, TATA box, CAAT box and SPl-binding sites (Batchelor • & O'Hare, 1990; Wechsler et al., 1989; Zwaagstra et al., 1991) , and a cAMP-responsive element binding site (Leib et al., 1991) . Located near the TATA box is a palindromic sequence which binds a nuclear factor, called latency-promoter binding factor (LPBF; Zwaagstra et at., 1991) . Deletion of the CCACGTGG sequence results in a loss of binding of LPBF from the minimal promoter region and an eight-to 30-fold reduction in promoter activity in both neuronal and nonneuronal cells. This suggests that LPBF may play a major role in the LAT promoter region. On analysis of the EHV-1 BamHI E fragment for the homologous region, a promoter region (similar to HSV-1) was observed (Fig. 3) . This region was located approximately 700 bp from the 3' end of gene 63 and had the common sites for RNA polymerase II transcription. These sites were a TATA box, CAAT box, SPl-binding site and LPBF region. The putative EHV-1 LPBF (Telford et al., 1992) . Consensus transcription factor-binding motifs, including a putative LPBF motif (Zwaagstra et al., 1991) (CCAGCTGG) differed from the HSV-I LPBF only in the interchange of two central bases in the palindromic sequences, where instead of CG we observe GC in the EHV-1 promoter region. Since the deletion of the HSV-I LPBF causes a decrease in promoter activity in the transcription of HSV-1 EATs we speculate that the change observed in the EHV-I genome may decrease the promoter activity for EHV-1 EATs, explaining why a very low number of EAT-positive neurons were observed. The role of the putative EHV-1 EAT promoter is being investigated further. The detection of EATs in EHV-1-infected tissues may lead to a better understanding of EHV-1 latency. However, the study has been hindered by the paucity of positive neurons in the latently-infected ganglia. These results show that EHV-1 closely resembles other members of the Alphaherpesvirinae. Studies are in progress to extend the observations to lymphoid tissues and to compare the transcriptional activity during latency and following suitable reactivation stimuli.
